Sonrotoclax
Sonrotoclax is a potent, orally active inhibitor of Bcl2, demonstrating effective cell-killing activity against a range of lymphoma and leukemia cell lines .
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
890.1
Molecular Formula
C49H59N7O7S
Notes
Research use only, not for human use.
Receptor
BCL
CAS Number
2383086-06-2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
